If it were up to Public Citizen, we should not be taking any new drugs until they were on the market for at least seven years:
Nearly lost in the controversy over Glaxo’s Avandia is a strongly worded statement issued the other day by Public Citizen, the advocacy group, about Merck’s relatively new diabetes pill, which was approved last fall by the FDA. On its web site, the group cautions that Januvia shouldn’t be used for another seven years, because the drug’s long-term safety is still unknown.
